Robust Execution Throughout Segments; Outcomes Broadly In Line with Expectations
Third quarter highlights
-
Third quarter earnings per share (EPS*) from persevering with operations decreased 73.8 % to $0.33, in contrast with EPS of $1.27 within the year-ago quarter; persevering with operations adjusted** EPS decreased 30.0 % to $0.96, down 28.9 % on a continuing foreign money foundation in opposition to sturdy development of 93.6 % within the year-ago quarter reflecting peak COVID-19 vaccine volumes -
12 months-to-date EPS from persevering with operations elevated 190.6 % to $5.49, in contrast with EPS of $1.89 within the year-ago quarter; persevering with operations adjusted EPS elevated 13.3 % to $4.23, up 13.9 % on a continuing foreign money foundation -
Third quarter gross sales from persevering with operations decreased 4.2 % over the year-ago quarter to $32.6 billion, down 2.8 % on a continuing foreign money foundation together with a 720 foundation level affect from AllianceRx Walgreens as anticipated -
Third quarter working revenue from persevering with operations decreased to a lack of $320 million, in comparison with working revenue of $1.1 billion within the year-ago quarter; adjusted working revenue from persevering with operations was $1.0 billion, down 33.5 % on a continuing foreign money foundation -
WBA bought 6.0 million shares of AmerisourceBergen widespread inventory, with proceeds of $900 million -
Completion of Boots strategic overview, with determination to retain the enterprise
Operational execution
-
WBA continues to assist shield native communities in opposition to COVID-19, with Walgreens administering 4.7 million vaccines and three.9 million exams within the third quarter -
U.S. retail comparable gross sales grew 2.4 % excluding tobacco -
Boots UK retail comparable gross sales grew 24.0 % with market share good points throughout all main classes -
Walgreens Well being professional forma gross sales up 65 % in comparison with year-ago standalone outcomes -
Transformational Value Administration Program now anticipated to ship $3.5 billion in annual price financial savings by fiscal 2024, up from $3.3 billion beforehand -
Focusing labor investments to return ~3,000 shops to regular working hours
Latest Walgreens Well being developments
-
Introduced strategic partnership with Buckeye Well being Plan, with over 400,000 lined lives -
Exceeded 2 million goal for lined lives by finish of CY22, with entry to over 2.3 million sufferers -
Launched medical trials enterprise, leveraging WBA’s consumer-centric mannequin to enhance entry and variety
Fiscal 2022 outlook
-
Sustaining full yr adjusted EPS steerage of low-single digit development, as year-to-date efficiency is monitoring broadly consistent with expectations
DEERFIELD, In poor health.–(BUSINESS WIRE)–
Walgreens Boots Alliance, Inc. (Nasdaq: WBA) at this time introduced monetary outcomes for the third quarter of fiscal 2022, which ended Could 31, 2022.
Chief Govt Officer Rosalind Brewer stated:
“WBA delivered sturdy execution throughout working segments and in opposition to very sturdy development final yr. Third quarter outcomes had been broadly consistent with our expectations, demonstrating the resilience of our enterprise by means of our deep group connections and relevance to customers. Walgreens Well being achieved 65 % professional forma gross sales development with progress on a number of fronts, together with including Buckeye Well being Plan as a strategic companion, already exceeding our 2022 goal for lined lives, and launching our medical trials enterprise. With our determination to conclude the Boots strategic overview, I firmly consider that our strategic actions are working to ship long-term shareholder worth.”
Overview of Third Quarter Outcomes
WBA third quarter gross sales from persevering with operations decreased 4.2 % from the year-ago quarter to $32.6 billion, a lower of two.8 % on a continuing foreign money foundation. Gross sales development at Walgreens and within the Worldwide phase, and gross sales contributions from the Walgreens Well being phase had been greater than offset by a 720 foundation level affect from the gross sales decline at AllianceRx Walgreens.
Third quarter working loss from persevering with operations was $320 million in comparison with working revenue of $1.1 billion within the year-ago quarter. Working loss within the quarter displays a $683 million cost associated to the opioid settlement with the State of Florida and better prices associated to the Transformational Value Administration Program. Adjusted working revenue from persevering with operations was $1.0 billion, a lower of 33.5 % on a continuing foreign money foundation. The decline in each adjusted and working revenue displays a lower in U.S. pharmacy working outcome because it lapped prior yr peak COVID-19 vaccinations, and development investments in Walgreens Well being, partly offset by improved retail contributions in each the U.S. and Worldwide segments.
Internet earnings from persevering with operations decreased 73.8 % to $289 million in comparison with $1.1 billion within the year-ago quarter. The decline displays the opioid settlement with the State of Florida, a lower in U.S. pharmacy working outcomes because it lapped prior yr peak COVID-19 vaccinations, and development investments in Walgreens Well being, partly offset by a acquire on the partial sale of the corporate’s fairness technique funding in AmerisourceBergen and the favorable affect of a decrease tax price in contrast with the year-ago quarter, in addition to improved retail contributions in each the U.S. and Worldwide segments. Adjusted internet earnings from persevering with operations decreased 30.2 % to $834 million, down 29.1 % on a continuing foreign money foundation in contrast with the year-ago quarter.
EPS from persevering with operations decreased 73.8 % to $0.33 in comparison with EPS of $1.27 within the year-ago quarter. Adjusted EPS from persevering with operations was $0.96, a lower of 30.0 % on a reported foundation and a lower of 28.9 % on a continuing foreign money foundation.
Internet money offered by working actions was $1.6 billion within the third quarter and free money movement was $1.3 billion, a $187 million lower in free money movement in contrast with the year-ago quarter pushed primarily by decrease U.S. working revenue, diminished quantity from the AllianceRx Walgreens enterprise, and elevated capital expenditures in development initiatives, partly offset by working capital.
Overview of Fiscal 2022 12 months-to-Date Outcomes
Gross sales from persevering with operations within the first 9 months of fiscal 2022 had been $100.3 billion, a rise of two.0 % from the identical interval a yr in the past, and a rise of two.7 % on a continuing foreign money foundation, reflecting comparable gross sales development at Walgreens and within the Worldwide phase and contributions from Walgreens Well being acquisitions, partly offset by a decline in gross sales at AllianceRx Walgreens.
Working revenue from persevering with operations within the first 9 months of fiscal 2022 elevated 54.3 % to $2.2 billion in comparison with $1.4 billion in the identical interval a yr in the past. This displays a $1.5 billion cost to the corporate’s fairness earnings from AmerisourceBergen within the prior fiscal yr, partly offset by a $683 million cost associated to the opioid settlement with the State of Florida within the present quarter. Adjusted working revenue from persevering with operations within the first 9 months of the fiscal yr was $4.4 billion, a rise of 13.1 % from the identical interval a yr in the past on a reported foundation, and up 13.7 % on a continuing foreign money foundation. The rise displays adjusted gross revenue development throughout each pharmacy and retail in the US and a continued rebound in Worldwide phase gross sales and profitability, partly offset by development investments in Walgreens Well being.
For the primary 9 months of fiscal 2022, internet earnings from persevering with operations elevated $3.1 billion in comparison with the identical interval a yr earlier, to $4.8 billion, reflecting a $2.5 billion after-tax acquire within the first quarter as a result of remeasurement of the corporate’s beforehand held investments in VillageMD and Shields, and a $1.2 billion cost, internet of tax, within the prior fiscal yr from the corporate’s fairness earnings in AmerisourceBergen. This was partly offset by the cost associated to the Florida opioid settlement within the present quarter. Adjusted internet earnings from persevering with operations elevated 13.3% to $3.7 billion, up 13.9% on a continuing foreign money foundation.
EPS from persevering with operations for the primary 9 months of fiscal 2022 elevated $3.60 to $5.49, in comparison with the identical interval a yr in the past. Adjusted EPS from persevering with operations was $4.23, a rise of 13.3 % from the identical interval a yr in the past on a reported foundation and a rise of 13.9 % on a continuing foreign money foundation.
Internet money offered by working actions was $3.8 billion within the first 9 months of fiscal 2022, a lower of $497 million from the identical interval final yr, and free money movement was $2.6 billion, a lower of $737 million from the identical interval a yr in the past pushed by diminished quantity from the AllianceRx Walgreens enterprise, the absence of COVID-19 associated authorities assist, and elevated capital expenditures in development initiatives, together with the VillageMD footprint enlargement and the rollout of latest automated microfulfillment facilities, partly offset by working capital initiatives and timing advantages.
Enterprise Highlights
WBA continued to execute on its technique and obtain sturdy outcomes throughout its companies, together with:
Rising the core
-
Taking part in a number one position in COVID-19 vaccinations and testing
– Walgreens administered 4.7 million vaccinations and three.9 million exams in 3Q
– Over 16 million boosters administered for this system so far -
U.S. retail comparable gross sales development of 1.4 %, or 2.4 % excluding tobacco -
U.S. digital gross sales development of 25 % in 3Q, on high of 95 % within the year-ago interval, pushed by 2.8 million similar day pick-up orders -
Grew MyWalgreens membership to over 99 million members on the finish of 3Q -
Just lately opened fourth automated microfulfillment heart, supporting ~1,100 shops complete with extra areas being added as these amenities turn out to be absolutely operational -
Expanded the corporate’s partnership with ALTO US, a supplier of modern loss prevention and tech-enabled safety providers, throughout greater than 2,200 shops nationwide -
Boots UK retail comparable gross sales development of 24.0 % -
Launched No7 Professional Derm Scan expertise and personalised session service in over 400 Boots shops in April -
Reached practically 500,000 buyer orders for modern digital healthcare service Boots On-line Physician since launching a yr in the past -
Focusing labor investments to return ~3,000 shops to regular working hours
Creating Walgreens Well being
-
Introduced strategic partnership with Buckeye Well being Plan, with over 400,000 lined lives -
Exceeded 2 million goal for lined lives by finish of CY22, with entry to 2.3 million sufferers -
Launched medical trials enterprise, leveraging WBA’s consumer-centric mannequin to enhance entry and variety -
CareCentrix transaction now anticipated by the top of 4Q, topic to regulatory approval -
Continued the rollout of VillageMD with 120 co-located clinics now open, on monitor towards 200 by finish of CY22 -
Shields contract wins with three important well being programs -
Established 56 Walgreens Well being Corners so far, on monitor towards 100 by finish of CY22 -
Over 60,000 shopper conversations performed by Walgreens Well being Nook Advisors in 3Q
Refocusing the portfolio and optimizing capital allocation
-
Offered 6.0 million shares of AmerisourceBergen widespread inventory, with proceeds of $900 million -
Supplied discover for the early compensation of the $731.4 million due with the corporate’s September 2022 notes, going down on July 5, 2022 -
Completion of Boots strategic overview, with determination to retain the enterprise
Constructing a high-performance tradition and successful group
-
Appointed three executives to Walgreens retail merchandise and buyer management group: Linh Peters as SVP and Chief Advertising Officer, Luke Rauch as SVP and Chief Merchandising Officer, and Bala Visalatha as SVP and Chief Product Officer -
Launched Be Properly Linked, the corporate’s group member program for psychological well being and wellbeing -
Improved the corporate’s world engagement rating to 72, a rise of two factors from the September 2021 degree -
Celebrated Pink Nostril Day for the eighth consecutive yr because the unique retailer of the nationwide marketing campaign to assist finish the cycle of kid poverty and guarantee a wholesome future for all kids
– Pink Nostril Day has raised $275 million since launching within the U.S. in 2015, positively impacting the lives of 30 million kids, and Walgreens has raised greater than $140 million towards that complete
Enterprise Segments
United States:
The US phase had third quarter gross sales of $26.7 billion, a lower of seven.1 % from the year-ago quarter, pushed by a decline within the AllianceRx Walgreens enterprise. Comparable gross sales elevated 1.8 % from the year-ago quarter.
Pharmacy gross sales decreased 9.7 % in comparison with the year-ago quarter, negatively impacted by an 11 proportion level headwind from the AllianceRx Walgreens enterprise. Comparable pharmacy gross sales elevated 2.0 % within the quarter in comparison with a yr in the past. Comparable prescriptions stuffed decreased 1.8 %; excluding immunizations, comparable prescriptions elevated 2.1 %. Whole prescriptions stuffed within the quarter decreased 2.5 % to 304 million, together with immunizations, adjusted to 30-day equivalents.
Retail gross sales elevated 1.0 % and comparable retail gross sales elevated 1.4 % in comparison with the year-ago quarter. Excluding tobacco and e-cigarettes, comparable retail gross sales elevated 2.4 %. The rise displays sturdy development in well being and wellness, which elevated 7.9 % aided by at-home COVID-19 exams and cough chilly flu and a 2.6 % improve in private care, partly offset by magnificence, and consumables and basic merchandise, which decreased 0.4 % and 1.9 %, respectively. Consumables and basic merchandise lapped sturdy gross sales in COVID-19 associated gadgets and had been impacted by the deliberate decline in tobacco.
Gross revenue decreased 9.8 % to $5.5 billion in comparison with $6.1 billion within the year-ago quarter. Adjusted gross revenue decreased 9.6 % to $5.6 billion in comparison with the year-ago quarter, reflecting a decline in pharmacy outcomes because it lapped prior yr peak COVID-19 vaccinations, partly offset by constructive contributions from retail efficiency.
Promoting, basic and administrative bills (SG&A) elevated 15.0 % to $5.7 billion in comparison with $5.0 billion within the yr in the past quarter, together with a $683 million cost associated to an accrual for the aforementioned opioid settlement with the State of Florida and better prices associated to the Transformational Value Administration Program. Adjusted SG&A decreased 0.9 % to $4.8 billion, pushed by decrease volumes of COVID-19 vaccinations and price self-discipline, partly offset by elevated labor prices and the timing of promoting expenditures.
Working loss within the third quarter decreased to $90 million in comparison with working revenue of $1.2 billion within the year-ago quarter reflecting the opioid settlement with the State of Florida and better Transformational Value Administration Program prices. Adjusted working revenue decreased 34.4 % to $966 million in comparison with $1.5 billion within the year-ago quarter reflecting sturdy prior interval outcomes which included peak COVID-19 vaccination volumes, with constructive contributions from development at retail within the present interval.
Worldwide:
The Worldwide phase had third quarter gross sales of $5.3 billion, a rise of 0.3 % from the year-ago quarter, together with an adversarial foreign money affect of 9.0 %. Gross sales elevated 9.3 % on a continuing foreign money foundation, with Boots UK gross sales rising 13.5 %, and our German wholesale enterprise rising 6.8 %.
Boots UK comparable pharmacy gross sales decreased 0.4 % in comparison with the year-ago quarter. Progress in comparable Nationwide Well being Service (NHS) volumes was greater than offset by favorable timing on NHS reimbursement within the year-ago quarter. Boots UK comparable retail gross sales elevated 24.0 % in comparison with the year-ago quarter, with market share good points throughout all classes, led by magnificence. Footfall improved in comparison with the year-ago quarter; nevertheless, visitors stays beneath pre-COVID-19 ranges. Boots.com continued to carry out effectively, accounting for over 13 % of retail gross sales within the quarter in comparison with 6 % pre-pandemic.
Gross revenue elevated 3.2 % in comparison with the identical quarter a yr in the past, together with an adversarial foreign money affect of 8.0 %. Adjusted gross revenue elevated 11.3 % on a continuing foreign money foundation, reflecting sturdy gross sales development within the UK.
SG&A within the quarter decreased 2.9 % from the year-ago quarter to $1.0 billion, together with a good foreign money affect of seven.0 %. Adjusted SG&A elevated 2.4 % on a continuing foreign money foundation. Excluding foreign money impacts, the rise in each SG&A and adjusted SG&A displays elevated investments in labor and advertising and marketing, and COVID-19 associated authorities assist within the year-ago quarter, partly offset by a acquire within the UK from a leaseback transaction.
Working revenue elevated to $100 million in comparison with $36 million within the year-ago quarter. Working revenue was negatively impacted 36.9 proportion factors ($13 million) because of foreign money translation. Adjusted working revenue grew strongly to $174 million, greater than doubling the year-ago quarter on a continuing foreign money foundation.
Walgreens Well being:
The corporate’s Walgreens Well being phase, created originally of fiscal yr 2022, is a consumer-centric, technology-enabled healthcare enterprise that engages customers by means of a personalised, omnichannel expertise throughout the care journey. Walgreens Well being will ship improved well being outcomes and decrease prices for payors and suppliers by delivering care by means of owned and partnered belongings.
The Walgreens Well being phase at the moment consists of:
-
A majority place in VillageMD, a number one, nationwide supplier of value-based major care providers; -
A majority place in Shields, a specialty pharmacy integrator and accelerator for hospitals; and -
The Walgreens Well being organically-developed enterprise that contracts with payors and suppliers to ship medical healthcare providers to their members and members’ caregivers by means of each digital and bodily channels.
The Walgreens Well being phase had third quarter gross sales of $596 million. On a professional forma foundation, in comparison with their year-ago standalone outcomes, these companies grew gross sales at a mixed price of 65 % within the quarter. Shields grew 47 %, pushed by key contract wins, additional enlargement of present partnerships, and robust executional focus. VillageMD grew 69 %, reflecting present clinic development and footprint enlargement.
Gross loss and adjusted gross loss had been every $21 million. Shields gross revenue, pushed by additional development at present partnerships and increasing margins, was greater than offset by development investments at VillageMD. As of the top of the third quarter, VillageMD had 315 complete clinics open, a rise of 97 clinics in comparison with the year-ago quarter.
Third quarter SG&A was $213 million, and adjusted SG&A was $108 million reflecting the 2 acquisitions, in addition to continued investments within the Walgreens Well being organically-developed enterprise. Adjusted SG&A excludes sure prices associated to inventory compensation expense and amortization of acquired intangible belongings. Working loss was $234 million. Adjusted working loss was $129 million.
Convention Name
WBA will maintain a convention name to debate the third quarter outcomes starting at 8:30 a.m. Jap time at this time, 2022. The convention name shall be simulcast by means of the WBA investor relations web site at: http://investor.walgreensbootsalliance.com. A replay of the convention name shall be archived on the web site for 12 months after the decision.
*All references to internet earnings are to internet earnings attributable to WBA and all references to EPS are to diluted EPS attributable to WBA.
**”Adjusted,” “fixed foreign money” and free money movement quantities are non-GAAP monetary measures. See the appendix to this launch for a dialogue of non-GAAP monetary measures, together with a reconciliation to probably the most carefully correlated GAAP measure.
Cautionary Be aware Relating to Ahead-Trying Statements: This launch comprises forward-looking statements made pursuant to the secure harbor provisions of the Non-public Securities Litigation Reform Act of 1995. These embody, with out limitation, estimates of and targets for future working, monetary and tax efficiency and outcomes, together with our fiscal yr 2022 steerage, our long-term development algorithm and associated assumptions and drivers, in addition to forward-looking statements regarding the anticipated execution and impact of our enterprise methods, together with the potential impacts on our enterprise of the unfold and impacts of COVID-19, our cost-savings and development initiatives, together with statements referring to our anticipated price financial savings beneath our Transformational Value Administration and enlargement of our Walgreens Well being phase, together with the anticipated closing of our CareCentrix transaction. All statements sooner or later tense and all statements accompanied by phrases akin to “anticipate,” “outlook,” “forecast,” “would,” “may,” “ought to,” “can,” “will,” “challenge,” “intend,” “plan,” “purpose,” “steerage,” “goal,” “intention,” proceed,” “rework,” “speed up,” “mannequin,” “long-term,” “consider,” “search,” “estimate,” “anticipate,” “could,” “doable,” “assume,” and variations of such phrases and related expressions are supposed to determine such forward-looking statements.
These forward-looking statements aren’t ensures of future efficiency and are topic to dangers, uncertainties and assumptions, identified or unknown, that would trigger precise outcomes to range materially from these indicated or anticipated.
These dangers, assumptions and uncertainties embody these described in Merchandise 1A (Danger Elements) of our Type 10-Okay for the fiscal yr ended August 31, 2021, as amended, and in different paperwork that we file or furnish with the Securities and Change Fee. If a number of of those dangers or uncertainties materializes, or if underlying assumptions show incorrect, precise outcomes could range materially from these indicated or anticipated by such forward-looking statements. All forward-looking statements we make or which are made on our behalf are certified by these cautionary statements. You shouldn’t place undue reliance on forward-looking statements, which communicate solely as of the date they’re made.
We don’t undertake, and expressly disclaim, any obligation or obligation to replace publicly any forward-looking assertion after the date of this launch, whether or not because of new data, future occasions, adjustments in assumptions or in any other case.
Please confer with the supplemental data introduced beneath for reconciliations of the non-GAAP monetary measures used on this launch to probably the most comparable GAAP monetary measure and associated disclosures.
Notes to Editors:
About Walgreens Boots Alliance
Walgreens Boots Alliance (Nasdaq: WBA) is an built-in healthcare, pharmacy and retail chief serving thousands and thousands of shoppers and sufferers on daily basis, with a 170-year heritage of caring for communities.
A trusted, world innovator in retail pharmacy with roughly 13,000 areas throughout the U.S., Europe and Latin America, WBA performs a vital position within the healthcare ecosystem. The corporate is reimagining native healthcare and well-being for all as a part of its objective – to create extra joyful lives by means of higher well being. Via meting out medicines, enhancing entry to a variety of well being providers, offering prime quality well being and sweetness merchandise and providing anytime, anyplace comfort throughout its digital platforms, WBA is shaping the way forward for healthcare.
WBA has greater than 315,000 group members and a presence in 9 international locations by means of its portfolio of shopper manufacturers: Walgreens, Boots, Duane Reade, the No7 Magnificence Firm, Benavides in Mexico and Ahumada in Chile. Moreover, WBA has a portfolio of healthcare-focused investments situated in a number of international locations, together with China and the U.S.
The corporate is happy with its contributions to wholesome communities, a wholesome planet, an inclusive office and a sustainable market. WBA has been acknowledged for its dedication to working sustainably: it’s an index part of the Dow Jones Sustainability Indices (DJSI) and was named to the 100 Greatest Company Residents 2021.
Extra firm data is offered at www.walgreensbootsalliance.com.
(WBA-ER)
|
|
|||||||||||||||
|
|
|
|
|
||||||||||||
|
|
|
|
|
|
|
|
|
||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||
|
|
|
|
|
|
|
|
|
|
|
||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||
|
|
|
|
|
|
||
|
|
|
|
|
|
||
|
|
|
|
|
|
||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||
|
|
|
|
|
|
||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||
|
|
|
|
|
|
||
|
|
|
|
|
|
||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||
|
|
|
|
|
|
||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||
|
|
|
|
||||||
|
|
|
|
|
|
||||
|
|
|
|
|
|
||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
WALGREENS BOOTS ALLIANCE, INC. AND SUBSIDIARIES
SUPPLEMENTAL INFORMATION (UNAUDITED)
REGARDING NON-GAAP FINANCIAL MEASURES
(in thousands and thousands, besides per share quantities)
The next data offers reconciliations of the supplemental non-GAAP monetary measures, as outlined beneath SEC guidelines, introduced on this press launch to probably the most instantly comparable monetary measures calculated and introduced in accordance with usually accepted accounting rules in the US (GAAP). The corporate has offered the non-GAAP monetary measures within the press launch, which aren’t calculated or introduced in accordance with GAAP, as supplemental data and along with the monetary measures which are calculated and introduced in accordance with GAAP.
These supplemental non-GAAP monetary measures are introduced as a result of administration has evaluated the corporate’s monetary outcomes each together with and excluding the adjusted gadgets or the results of international foreign money translation, as relevant, and believes that the supplemental non-GAAP monetary measures introduced present further perspective and insights when analyzing the core working efficiency of the corporate’s enterprise from interval to interval and developments within the firm’s historic working outcomes. These supplemental non-GAAP monetary measures shouldn’t be thought of superior to, as an alternative choice to or as a substitute for, and must be thought of together with, the GAAP monetary measures introduced within the press launch.
The corporate doesn’t present a reconciliation for non-GAAP estimates on a forward-looking foundation the place it’s unable to offer a significant or correct calculation or estimation of reconciling gadgets and the knowledge shouldn’t be accessible with out unreasonable effort. That is as a result of inherent problem of forecasting the timing or quantity of assorted gadgets that haven’t but occurred, are out of the corporate’s management and/or can’t be moderately predicted, and that will affect diluted internet earnings per share, probably the most instantly comparable forward-looking GAAP monetary measure. For a similar causes, the corporate is unable to deal with the possible significance of the unavailable data. Ahead-looking non-GAAP monetary measures offered with out probably the most instantly comparable GAAP monetary measures could range materially from the corresponding GAAP monetary measures.
Fixed foreign money
The corporate additionally presents sure data associated to present interval working leads to “fixed foreign money,” which is a non-GAAP monetary measure. These quantities are calculated by translating present interval outcomes on the international foreign money alternate charges used within the comparable interval within the prior yr. The corporate presents such fixed foreign money monetary data as a result of it has important operations exterior of the US reporting in currencies apart from the U.S. greenback and this presentation offers a framework to evaluate how its enterprise carried out excluding the affect of international foreign money alternate price fluctuations.
Comparable gross sales
For the corporate’s United States and Worldwide segments, comparable gross sales are outlined as gross sales from shops which have been open for no less than 12 consecutive months with out closure for seven or extra consecutive days, together with on account of looting or retailer injury, and with out a main transform or being topic to a pure catastrophe up to now 12 months in addition to e-commerce gross sales. E-commerce gross sales embody digitally initiated gross sales on-line or by means of cellular functions. Relocated shops aren’t included as comparable shops for the primary 12 months after the relocation. Acquired shops aren’t included as comparable gross sales for the primary 12 months after acquisition or conversion, when relevant, whichever is later. Comparable gross sales, comparable pharmacy gross sales, comparable retail gross sales, comparable variety of prescriptions and comparable variety of 30-day equal prescriptions confer with complete gross sales, pharmacy gross sales, retail gross sales, variety of prescriptions and variety of 30-day equal prescriptions, respectively. The strategy of calculating comparable gross sales varies throughout the retail trade. Because of this, the corporate’s technique of calculating comparable gross sales is probably not the identical as different retailers’ strategies.
With respect to the Worldwide phase, comparable gross sales, comparable pharmacy gross sales and comparable retail gross sales, are introduced on a continuing foreign money foundation, which is a non-GAAP monetary measure. Seek advice from the dialogue above in “Fixed foreign money” for additional particulars on fixed foreign money calculations.
Key Efficiency Indicators
The corporate considers sure metrics, together with all comparable metrics, variety of prescriptions, variety of 30-day equal prescriptions and variety of areas at interval finish, to be key efficiency indicators as a result of the corporate’s administration has evaluated its outcomes of operations utilizing these metrics and believes that these key efficiency indicators introduced present further perspective and insights when analyzing the core working efficiency of the corporate from interval to interval and developments in its historic working outcomes. These key efficiency indicators shouldn’t be thought of superior to, as an alternative choice to or as a substitute for, and must be thought of together with, the GAAP monetary measures introduced herein. These measures is probably not akin to similarly-titled efficiency indicators utilized by different corporations.
|
|
|||||||||||||||
|
|
|
|
|
|
|
||||||||||
|
|
|
|
|
||||||||||||
|
|
|
|
|
|
|
|
|
||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||
|
|
|
|
|
|
|
|
|
||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||
|
|
|
|
|
|
|
|
|
||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||
|
|
|
|
|
|
|
|
|
||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||
|
|
|
|
|
|
|
|
|
||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||
|
|
|
|
|
|
|
|
|
||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||
|
|
|
|
|
|
|
|
|
||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||||||||||
|
|
|
|
||||||||||||||||||
|
|
|
|
||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||
|
|
|
|
|
|
|
|
|
|
||||||||||||||||||
|
|
|
|
||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||||||||
|
|
|
|
||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||
|
|
|
|
|
|
|
|
|
|
||||||||||||||||||
|
|
|
|
||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
|
|
|
|
|
|
|
|
|
|
|
||||||||||||||||
|
|
|
|
|
|
||||||||||||
|
|
|
|
|
|
|
|
|
|
||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||
|
|
|
|
|
|
|||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||||||
|
|
|
|
|
|
||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
View supply model on businesswire.com:
https://www.businesswire.com/information/residence/20220630005294/en/
Media Relations
U.S. / Jim Cohn, +1 224 813 9057
Worldwide, +44 (0)20 7980 8585
Investor Relations
Tiffany Kanaga, +1 847 315 2922
Supply: Walgreens Boots Alliance
